Table 3.
Pathway enrichment analysis for the 120 replicated metabolites associated with fat distribution.
| Metabolite set | Hits | Expected | Total | P-value |
|---|---|---|---|---|
| Aminoacyl-tRNA biosynthesis | 7 | 0.96 | 48 | 2.61E−05 |
| Valine, leucine and isoleucine biosynthesis | 3 | 0.16 | 8 | 3.80E−04 |
| Glycerophospholipid metabolism | 5 | 0.72 | 36 | 5.58E−04 |
| Histidine metabolism | 3 | 0.32 | 16 | 3.40E−03 |
| Sphingolipid metabolism | 3 | 0.42 | 21 | 7.55E−03 |
| Alanine, aspartate and glutamate metabolism | 3 | 0.56 | 28 | 1.69E−02 |
| Cysteine and methionine metabolism | 3 | 0.66 | 33 | 2.63E−02 |
| Arginine biosynthesis | 2 | 0.28 | 14 | 3.03E−02 |
| Nicotinate and nicotinamide metabolism | 2 | 0.30 | 15 | 3.46E−02 |
| Glycerolipid metabolism | 2 | 0.32 | 16 | 3.90E−02 |
| Valine, leucine and isoleucine degradation | 3 | 0.80 | 40 | 4.34E−02 |
Total, total number of metabolites in this metabolite set (pathway); expected, expected number of metabolites projected to each set; hits, observed number of metabolites of interest projected to each set.